Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 3957958, 19 pages
http://dx.doi.org/10.1155/2016/3957958
Review Article

Inflammatory Mechanisms Associated with Skeletal Muscle Sequelae after Stroke: Role of Physical Exercise

1Faculty of Physical Education, University of Campinas (UNICAMP), 13083-851 Campinas, SP, Brazil
2Exercise and Immunometabolism Research Group, Department of Physical Education, São Paulo State University (UNESP), 19060-900 Presidente Prudente, SP, Brazil
3Human Movement Laboratory, São Judas Tadeu University (USJT), 03166-000 São Paulo, SP, Brazil

Received 3 June 2016; Accepted 26 July 2016

Academic Editor: Vera L. Petricevich

Copyright © 2016 Hélio José Coelho Junior et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Lozano, M. Naghavi, K. Foreman et al., “Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010,” The Lancet, vol. 380, no. 9859, pp. 2095–2128, 2012. View at Publisher · View at Google Scholar
  2. C. J. L. Murray, T. Vos, R. Lozano et al., “Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010,” The Lancet, vol. 380, no. 9859, pp. 2197–2223, 2012. View at Publisher · View at Google Scholar
  3. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart disease and stroke statistics—2014 update: a report from the American Heart Association,” Circulation, vol. 129, no. 3, pp. e28–e292, 2014. View at Publisher · View at Google Scholar
  4. V. L. Feigin, C. M. Lawes, D. A. Bennett, S. L. Barker-Collo, and V. Parag, “Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review,” The Lancet Neurology, vol. 8, no. 4, pp. 355–369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. C. English, H. McLennan, K. Thoirs, A. Coates, and J. Bernhardt, “Loss of skeletal muscle mass after stroke: a systematic review,” International Journal of Stroke, vol. 5, no. 5, pp. 395–402, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Scherbakov, A. Sandek, and W. Doehner, “Stroke-related sarcopenia: specific characteristics,” Journal of the American Medical Directors Association, vol. 16, no. 4, pp. 272–276, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Scherbakov, S. Von Haehling, S. D. Anker, U. Dirnagl, and W. Doehner, “Stroke induced Sarcopenia: muscle wasting and disability after stroke,” International Journal of Cardiology, vol. 170, no. 2, pp. 89–94, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Costamagna, P. Costelli, M. Sampaolesi, and F. Penna, “Role of inflammation in muscle homeostasis and myogenesis,” Mediators of Inflammation, vol. 2015, Article ID 805172, 14 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Londhe and D. C. Guttridge, “Inflammation induced loss of skeletal muscle,” Bone, vol. 80, pp. 131–142, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. S. A. Billinger, R. Arena, J. Bernhardt et al., “Physical activity and exercise recommendations for stroke survivors: a statement for healthcare professionals from the American Heart Association/American Stroke Association,” Stroke, vol. 45, no. 8, pp. 2532–2553, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. J. V. Francica, A. Bigongiari, L. Mochizuki et al., “Cardiac autonomic dysfunction in chronic stroke women is attenuated after submaximal exercise test, as evaluated by linear and nonlinear analysis,” BMC Cardiovascular Disorders, vol. 15, no. 1, article 105, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. D. H. Saunders, C. A. Greig, and G. E. Mead, “Physical activity and exercise after stroke: review of multiple meaningful benefits,” Stroke, vol. 45, no. 12, pp. 3742–3747, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Gleeson, N. C. Bishop, D. J. Stensel, M. R. Lindley, S. S. Mastana, and M. A. Nimmo, “The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease,” Nature Reviews Immunology, vol. 11, no. 9, pp. 607–610, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. B. K. Pedersen, “Muscles and their myokines,” The Journal of Experimental Biology, vol. 214, no. 2, pp. 337–346, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. W. Petersen and B. K. Pedersen, “The anti-inflammatory effect of exercise,” Journal of Applied Physiology, vol. 98, no. 4, pp. 1154–1162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Brandt and B. K. Pedersen, “The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 520258, 6 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. S. Rafii and A. E. Hillis, “Compendium of cerebrovascular diseases,” International Review of Psychiatry, vol. 18, no. 5, pp. 395–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Carda, C. Cisari, and M. Invernizzi, “Sarcopenia or muscle modifications in neurologic diseases: a lexical or patophysiological difference?” European Journal of Physical and Rehabilitation Medicine, vol. 49, no. 1, pp. 119–130, 2013. View at Google Scholar · View at Scopus
  19. C. E. Hafer-Macko, A. S. Ryan, F. M. Ivey, and R. F. Macko, “Skeletal muscle changes after hemiparetic stroke and potential beneficial effects of exercise intervention strategies,” Journal of Rehabilitation Research and Development, vol. 45, no. 2, pp. 261–272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. W. Ramsay, P. J. Barrance, T. S. Buchanan, and J. S. Higginson, “Paretic muscle atrophy and non-contractile tissue content in individual muscles of the post-stroke lower extremity,” Journal of Biomechanics, vol. 44, no. 16, pp. 2741–2746, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Scherbakov and W. Doehner, “Sarcopenia in stroke-facts and numbers on muscle loss accounting for disability after stroke,” Journal of Cachexia, Sarcopenia and Muscle, vol. 2, no. 1, pp. 5–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Lazoura, P. J. Papadaki, E. Antoniadou et al., “Skeletal and body composition changes in hemiplegic patients,” Journal of Clinical Densitometry, vol. 13, no. 2, pp. 175–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. C. L. Prado-Medeiros, M. P. Silva, G. C. Lessi et al., “Muscle atrophy and functional deficits of knee extensors and flexors in people with chronic stroke,” Physical Therapy, vol. 92, no. 3, pp. 429–439, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Kortebein, A. Ferrando, J. Lombeida, R. Wolfe, and W. J. Evans, “Effect of 10 days of bed rest on skeletal muscle in healthy older adults,” The Journal of the American Medical Association, vol. 297, no. 16, pp. 1769–1774, 2007. View at Google Scholar · View at Scopus
  25. Z. A. Puthucheary, J. Rawal, M. McPhail et al., “Acute skeletal muscle wasting in critical illness,” The Journal of the American Medical Association, vol. 310, no. 15, pp. 1591–1600, 2013. View at Google Scholar
  26. L. Jorgensen and B. K. Jacobsen, “Changes in muscle mass, fat mass, and bone mineral content in the legs after stroke: a 1 year prospective study,” Bone, vol. 28, no. 6, pp. 655–659, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. A. W. Andrews and R. W. Bohannon, “Distribution of muscle strength impairments following stroke,” Clinical Rehabilitation, vol. 14, no. 1, pp. 79–87, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. C. M. Kim and J. J. Eng, “The relationship of lower-extremity muscle torque to locomotor performance in people with stroke,” Physical Therapy, vol. 83, no. 1, pp. 49–57, 2003. View at Google Scholar · View at Scopus
  29. D. Pradon, N. Roche, L. Enette, and R. Zory, “Relationship between lower limb muscle strength and 6-minute walk test performance in stroke patients,” Journal of Rehabilitation Medicine, vol. 45, no. 1, pp. 105–108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. E. Morley, B. Vellas, G. Abellan van Kan et al., “Frailty consensus: a call to action,” Journal of the American Medical Directors Association, vol. 14, no. 6, pp. 392–397, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Sions, C. M. Tyrell, B. A. Knarr, A. Jancosko, and S. A. Binder-Macleod, “Age- and stroke-related skeletal muscle changes: a review for the geriatric clinician,” Journal of Geriatric Physical Therapy, vol. 35, no. 3, pp. 155–161, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. R. Deschenes, “Effects of aging on muscle fibre type and size,” Sports Medicine, vol. 34, no. 12, pp. 809–824, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. J. A. Faulkner, L. M. Larkin, D. R. Claflin, and S. V. Brooks, “Age-related changes in the structure and function of skeletal muscles,” Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 11, pp. 1091–1096, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. P. G. De Deyne, C. E. Hafer-Macko, F. M. Ivey, A. S. Ryan, and R. F. Macko, “Muscle molecular phenotype after stroke is associated with gait speed,” Muscle and Nerve, vol. 30, no. 2, pp. 209–215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. M. B. Reid, A. R. Judge, and S. C. Bodine, “CrossTalk opposing view: the dominant mechanism causing disuse muscle atrophy is proteolysis,” Journal of Physiology, vol. 592, no. 24, pp. 5345–5347, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Zhang, X. Chen, and M. Fan, “Signaling mechanisms involved in disuse muscle atrophy,” Medical Hypotheses, vol. 69, no. 2, pp. 310–321, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Bonaldo and M. Sandri, “Cellular and molecular mechanisms of muscle atrophy,” Disease Models and Mechanisms, vol. 6, no. 1, pp. 25–39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Musarò, K. McCullagh, A. Paul et al., “Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle,” Nature Genetics, vol. 27, no. 2, pp. 195–200, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. T. N. Stitt, D. Drujan, B. A. Clarke et al., “The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors,” Molecular Cell, vol. 14, no. 3, pp. 395–403, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. D. J. Glass, “Molecular mechanisms modulating muscle mass,” Trends in Molecular Medicine, vol. 9, no. 8, pp. 344–350, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Latres, A. R. Amini, A. A. Amini et al., “Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway,” The Journal of Biological Chemistry, vol. 280, no. 4, pp. 2737–2744, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Csibi, K. Cornille, M.-P. Leibovitch et al., “The translation regulatory subunit eIF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse,” PLoS ONE, vol. 5, no. 2, Article ID e8994, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. S. C. Bodine, E. Latres, S. Baumhueter et al., “Identification of ubiquitin ligases required for skeletal muscle atrophy,” Science, vol. 294, no. 5547, pp. 1704–1708, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Lamas, M. S. Aoki, C. Ugrinowitsch et al., “Expression of genes related to muscle plasticity after strength and power training regimens,” Scandinavian Journal of Medicine and Science in Sports, vol. 20, no. 2, pp. 216–225, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. K. Powers, A. J. Smuder, and D. S. Criswell, “Mechanistic links between oxidative stress and disuse muscle atrophy,” Antioxidants & Redox Signaling, vol. 15, no. 9, pp. 2519–2528, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. J. M. Sacheck, A. Ohtsuka, S. C. McLary, and A. L. Goldberg, “IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1,” American Journal of Physiology —Endocrinology and Metabolism, vol. 287, no. 4, pp. E591–E601, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. M. M. Desgeorges, X. Devillard, J. Toutain et al., “Molecular mechanisms of skeletal muscle atrophy in a mouse model of cerebral ischemia,” Stroke, vol. 46, no. 6, pp. 1673–1680, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. M. D. A. Silva-Couto, C. L. Prado-Medeiros, A. B. Oliveira et al., “Muscle atrophy, voluntary activation disturbances, and low serum concentrations of IGF-1 and IGFBP-3 are associated with weakness in people with chronic stroke,” Physical Therapy, vol. 94, no. 7, pp. 957–967, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Åberg, K. Jood, C. Blomstrand et al., “Serum IGF-I levels correlate to improvement of functional outcome after ischemic stroke,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 7, pp. E1055–E1064, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Bernhardt, “Very early mobilization following acute stroke: controversies, the unknowns, and a way forward,” Annals of Indian Academy of Neurology, vol. 11, no. 5, pp. 88–98, 2008. View at Google Scholar · View at Scopus
  51. S. C. Bodine and L. M. Baehr, “Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1,” American Journal of Physiology—Endocrinology and Metabolism, vol. 307, no. 6, pp. E469–E484, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. M. D. De Boer, A. Selby, P. Atherton et al., “The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse,” The Journal of Physiology, vol. 585, no. 1, pp. 241–251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Gustafsson, T. Osterlund, J. N. Flanagan et al., “Effects of 3 days unloading on molecular regulators of muscle size in humans,” Journal of Applied Physiology, vol. 109, no. 3, pp. 721–727, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Springer, S. Schust, K. Peske et al., “Catabolic signaling and muscle wasting after acute ischemic stroke in mice: indication for a stroke-specific sarcopenia,” Stroke, vol. 45, no. 12, pp. 3675–3683, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. E. Masiero, L. Agatea, C. Mammucari et al., “Autophagy is required to maintain muscle mass,” Cell Metabolism, vol. 10, no. 6, pp. 507–515, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. E. Masiero and M. Sandri, “Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles,” Autophagy, vol. 6, no. 2, pp. 307–309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. F. von Walden, F. Jakobsson, L. Edström, and G. A. Nader, “Altered autophagy gene expression and persistent atrophy suggest impaired remodeling in chronic hemiplegic human skeletal muscle,” Muscle and Nerve, vol. 46, no. 5, pp. 785–792, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. A.-C. Durieux, A. Amirouche, S. Banzet et al., “Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression,” Endocrinology, vol. 148, no. 7, pp. 3140–3147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Carnac, S. Ricaud, B. Vernus, and A. Bonnieu, “Myostatin: biology and clinical relevance,” Mini-Reviews in Medicinal Chemistry, vol. 6, no. 7, pp. 765–770, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. J. F. Tobin and A. J. Celeste, “Myostatin, a negative regulator of muscle mass: implications for muscle degenerative diseases,” Current Opinion in Pharmacology, vol. 5, no. 3, pp. 328–332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. A. C. McPherron, A. M. Lawler, and S.-J. Lee, “Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member,” Nature, vol. 387, no. 6628, pp. 83–90, 1997. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Lin, H. B. Arnold, M. A. Della-Fera, M. J. Azain, D. L. Hartzell, and C. A. Baile, “Myostatin knockout in mice increases myogenesis and decreases adipogenesis,” Biochemical and Biophysical Research Communications, vol. 291, no. 3, pp. 701–706, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. L.-A. Whittemore, K. Song, X. Li et al., “Inhibition of myostatin in adult mice increases skeletal muscle mass and strength,” Biochemical and Biophysical Research Communications, vol. 300, no. 4, pp. 965–971, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Grobet, L. J. R. Martin, D. Poncelet et al., “A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle,” Nature Genetics, vol. 17, no. 1, pp. 71–74, 1997. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Schuelke, K. R. Wagner, L. E. Stolz et al., “Myostatin mutation associated with gross muscle hypertrophy in a child,” The New England Journal of Medicine, vol. 350, no. 26, pp. 2682–2688, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. D. Joulia-Ekaza and G. Cabello, “The myostatin gene: physiology and pharmacological relevance,” Current Opinion in Pharmacology, vol. 7, no. 3, pp. 310–315, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. A. U. Trendelenburg, A. Meyer, D. Rohner, J. Boyle, S. Hatakeyama, and D. J. Glass, “Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size,” American Journal of Physiology—Cell Physiology, vol. 296, no. 6, pp. C1258–C1270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. D. L. Allen, A. S. Cleary, S. F. Lindsay, A. S. Loh, and J. M. Reed, “Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice,” Journal of Applied Physiology, vol. 109, no. 3, pp. 692–701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. B. T. Wall, M. L. Dirks, T. Snijders, J. M. G. Senden, J. Dolmans, and L. J. C. Van Loon, “Substantial skeletal muscle loss occurs during only 5 days of disuse,” Acta Physiologica, vol. 210, no. 3, pp. 600–611, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. S. McCroskery, M. Thomas, L. Maxwell, M. Sharma, and R. Kambadur, “Myostatin negatively regulates satellite cell activation and self-renewal,” Journal of Cell Biology, vol. 162, no. 6, pp. 1135–1147, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. C. J. Carlson, F. W. Booth, and S. E. Gordon, “Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 277, no. 2, pp. R601–R606, 1999. View at Google Scholar · View at Scopus
  72. A. P. Baumann, C. Ibebunjo, W. A. Grasser, and V. M. Paralkar, “Myostatin expression in age and denervation-induced skeletal muscle atrophy,” Journal of Musculoskeletal Neuronal Interactions, vol. 3, no. 1, pp. 8–16, 2003. View at Google Scholar · View at Scopus
  73. A. S. Ryan, A. Buscemi, L. Forrester, C. E. Hafer-Macko, and F. M. Ivey, “Atrophy and intramuscular fat in specific muscles of the thigh: associated weakness and hyperinsulinemia in stroke survivors,” Neurorehabilitation and Neural Repair, vol. 25, no. 9, pp. 865–872, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. C. Franceschi, M. Bonafè, S. Valensin et al., “Inflamm-aging: an evolutionary perspective on immunosenescence,” Annals of the New York Academy of Sciences, vol. 908, pp. 244–254, 2000. View at Google Scholar · View at Scopus
  75. M. Seelaender, M. Batista, F. Lira, R. Silverio, and F. Rossi-Fanelli, “Inflammation in cancer cachexia: to resolve or not to resolve (is that the question?),” Clinical Nutrition, vol. 31, no. 4, pp. 562–566, 2012. View at Publisher · View at Google Scholar · View at Scopus
  76. H. Degens, “The role of systemic inflammation in age-related muscle weakness and wasting,” Scandinavian Journal of Medicine & Science in Sports, vol. 20, no. 1, pp. 28–38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. E. A. Flores, B. R. Bistrian, J. J. Pomposelli, C. A. Dinarello, G. L. Blackburn, and N. W. Istfan, “Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1,” The Journal of Clinical Investigation, vol. 83, no. 5, pp. 1614–1622, 1989. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Tsujinaka, C. Ebisui, J. Fujita et al., “Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse,” Biochemical and Biophysical Research Communications, vol. 207, no. 1, pp. 168–174, 1995. View at Publisher · View at Google Scholar · View at Scopus
  79. T. Tsujinaka, J. Fujita, C. Ebisui et al., “Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice,” The Journal of Clinical Investigation, vol. 97, no. 1, pp. 244–249, 1996. View at Publisher · View at Google Scholar · View at Scopus
  80. M. L. Batista Jr., J. C. Rosa, R. D. Lopes et al., “Exercise training changes IL-10/TNF-α ratio in the skeletal muscle of post-MI rats,” Cytokine, vol. 49, no. 1, pp. 102–108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. R. D. Lopes, M. L. Batista Jr., J. C. Rosa et al., “Changes in the production of IL-10 and TNF-α in skeletal muscle of rats with heart failure secondary to acute myocardial infarction,” Arquivos Brasileiros de Cardiologia, vol. 94, no. 3, pp. 313–320, 2010. View at Google Scholar · View at Scopus
  82. F. F. Donatto, R. X. Neves, F. O. Rosa et al., “Resistance exercise modulates lipid plasma profile and cytokine content in the adipose tissue of tumour-bearing rats,” Cytokine, vol. 61, no. 2, pp. 426–432, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. L. A. Schaap, S. M. F. Pluijm, D. J. H. Deeg et al., “Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength,” Journals of Gerontology—Series A Biological Sciences and Medical Sciences, vol. 64, no. 11, pp. 1183–1189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Visser, M. Pahor, D. R. Taaffe et al., “Relationship of interleukin-6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women: The Health ABC Study,” Journals of Gerontology—Series A Biological Sciences and Medical Sciences, vol. 57, no. 5, pp. M326–M332, 2002. View at Publisher · View at Google Scholar · View at Scopus
  85. M. L. Batista, M. Olivan, P. S. M. Alcantara et al., “Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients,” Cytokine, vol. 61, no. 2, pp. 532–539, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. S. D. Anker, P. P. Ponikowski, A. L. Clark et al., “Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure,” European Heart Journal, vol. 20, no. 9, pp. 683–693, 1999. View at Publisher · View at Google Scholar · View at Scopus
  87. L. A. Schaap, S. M. F. Pluijm, D. J. H. Deeg, and M. Visser, “Inflammatory markers and loss of muscle mass (Sarcopenia) and Strength,” The American Journal of Medicine, vol. 119, no. 6, pp. 526.e9–526.e17, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. M. B. Reid and Y.-P. Li, “Tumor necrosis factor-α and muscle wasting: a cellular perspective,” Respiratory Research, vol. 2, no. 5, pp. 269–272, 2001. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Di Francia, D. Barbier, J. L. Mege, and J. Orehek, “Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 150, no. 5, pp. 1453–1455, 1994. View at Publisher · View at Google Scholar · View at Scopus
  90. C. E. Hafer-Macko, S. Yu, A. S. Ryan, F. M. Ivey, and R. F. Macko, “Elevated tumor necrosis factor-α in skeletal muscle after stroke,” Stroke, vol. 36, no. 9, pp. 2021–2023, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. J. Zaremba and J. Losy, “Early TNF-α levels correlate with ischaemic stroke severity,” Acta Neurologica Scandinavica, vol. 104, no. 5, pp. 288–295, 2001. View at Publisher · View at Google Scholar · View at Scopus
  92. H. Nawashiro, K. Tasaki, C. A. Ruetzler, and J. M. Hallenbeck, “TNF-α pretreatment induces protective effects against focal cerebral ischemia in mice,” Journal of Cerebral Blood Flow and Metabolism, vol. 17, no. 5, pp. 483–490, 1997. View at Google Scholar · View at Scopus
  93. R. A. Frost, C. H. Lang, and M. C. Gelato, “Transient exposure of human myoblasts to tumor necrosis factor-α inhibits serum and insulin-like growth factor-I stimulated protein synthesis,” Endocrinology, vol. 138, no. 10, pp. 4153–4159, 1997. View at Publisher · View at Google Scholar · View at Scopus
  94. M. N. Goodman, “Tumor necrosis factor induces skeletal muscle protein breakdown in rats,” American Journal of Physiology-Endocrinology and Metabolism, vol. 260, no. 5, pp. E727–E730, 1991. View at Google Scholar · View at Scopus
  95. S. R. Broussard, R. H. Mccusker, J. E. Novakofski et al., “Cytokine-hormone interactions: tumor necrosis factor α impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts,” Endocrinology, vol. 144, no. 7, pp. 2988–2996, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. Y.-P. Li, R. J. Schwartz, I. D. Waddell, B. R. Holloway, and M. B. Reid, “Skeletal muscle myocytes undergo protein loss and reactive oxygen- mediated NF-κB activation in response to tumor necrosis factor α,” The FASEB Journal, vol. 12, no. 10, pp. 871–880, 1998. View at Google Scholar · View at Scopus
  97. T. Philips and C. Leeuwenburgh, “Muscle fiber specific apoptosis and TNF-α signaling in sarcopenia are attenuated by life-long calorie restriction,” The FASEB Journal, vol. 19, no. 6, pp. 668–670, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. J. M. Peterson, K. D. Feeback, J. H. Baas, and F. X. Pizza, “Tumor necrosis factor-α promotes the accumulation of neutrophils and macrophages in skeletal muscle,” Journal of Applied Physiology, vol. 101, no. 5, pp. 1394–1399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. M. El Assar, J. Angulo, and L. Rodríguez-Mañas, “Oxidative stress and vascular inflammation in aging,” Free Radical Biology and Medicine, vol. 65, pp. 380–401, 2013. View at Publisher · View at Google Scholar · View at Scopus
  100. D. Cai, J. D. Frantz, N. E. Tawa Jr. et al., “IKKβ/NF-κB activation causes severe muscle wasting in mice,” Cell, vol. 119, no. 2, pp. 285–298, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. R. W. Jackman, E. W. Cornwell, C.-L. Wu, and S. C. Kandarian, “Nuclear factor-κB signalling and transcriptional regulation in skeletal muscle atrophy,” Experimental Physiology, vol. 98, no. 1, pp. 19–24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. F. Mourkioti and N. Rosenthal, “NF-κB signaling in skeletal muscle: prospects for intervention in muscle diseases,” Journal of Molecular Medicine, vol. 86, no. 7, pp. 747–759, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. A. S. Ryan, C. L. Dobrovolny, G. V. Smith, K. H. Silver, and R. F. Macko, “Hemiparetic muscle atrophy and increased intramuscular fat in stroke patients,” Archives of Physical Medicine and Rehabilitation, vol. 83, no. 12, pp. 1703–1707, 2002. View at Publisher · View at Google Scholar · View at Scopus
  104. A. S. Ryan, F. M. Ivey, S. Prior, G. Li, and C. Hafer-Macko, “Skeletal muscle hypertrophy and muscle myostatin reduction after resistive training in stroke survivors,” Stroke, vol. 42, no. 2, pp. 416–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. M. L. Batista, F. S. Henriques, R. X. Neves et al., “Cachexia-associated adipose tissue morphological rearrangement in gastrointestinal cancer patients,” Journal of Cachexia, Sarcopenia and Muscle, vol. 7, no. 1, pp. 37–47, 2016. View at Publisher · View at Google Scholar
  106. R. G. Camargo, D. M. dos Reis Riccardi, H. Q. T. Ribeiro et al., “Nf-κbp65 and expression of its pro-inflammatory target genes are upregulated in the subcutaneous adipose tissue of cachectic cancer patients,” Nutrients, vol. 7, no. 6, pp. 4465–4479, 2015. View at Publisher · View at Google Scholar · View at Scopus
  107. F. S. Lira, J. C. Rosa, A. S. Yamashita, C. H. Koyama, M. L. Batista Jr., and M. Seelaender, “Endurance training induces depot-specific changes in IL-10/TNF-α ratio in rat adipose tissue,” Cytokine, vol. 45, no. 2, pp. 80–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. F. S. Lira, J. C. Rosa, N. E. Zanchi et al., “Regulation of inflammation in the adipose tissue in cancer cachexia: effect of exercise,” Cell Biochemistry and Function, vol. 27, no. 2, pp. 71–75, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. R. X. Neves, J. C. Rosa-Neto, A. S. Yamashita et al., “White adipose tissue cells and the progression of cachexia: inflammatory pathways,” Journal of Cachexia, Sarcopenia and Muscle, vol. 7, no. 2, pp. 193–203, 2016. View at Publisher · View at Google Scholar · View at Scopus
  110. E. M. de Matos-Neto, J. D. C. C. Lima, W. O. de Pereira et al., “Systemic inflammation in cachexia—is tumor cytokine expression profile the culprit?” Frontiers in Immunology, vol. 6, article 629, 2015. View at Publisher · View at Google Scholar · View at Scopus
  111. C. J. Hasson, J. A. Kent-Braun, and G. E. Caldwell, “Contractile and non-contractile tissue volume and distribution in ankle muscles of young and older adults,” Journal of Biomechanics, vol. 44, no. 12, pp. 2299–2306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. J.-Y. Hogrel, Y. Barnouin, N. Azzabou et al., “NMR imaging estimates of muscle volume and intramuscular fat infiltration in the thigh: variations with muscle, gender, and age,” Age, vol. 37, no. 3, article 60, pp. 1–11, 2015. View at Publisher · View at Google Scholar · View at Scopus
  113. O. Addison, M. J. Drummond, P. C. Lastayo et al., “Intramuscular fat and inflammation differ in older adults: the impact of frailty and inactivity,” The Journal of Nutrition, Health & Aging, vol. 18, no. 5, pp. 532–538, 2014. View at Publisher · View at Google Scholar · View at Scopus
  114. M. L. Batista, S. B. Peres, M. E. McDonald et al., “Adipose tissue inflammation and cancer cachexia: possible role of nuclear transcription factors,” Cytokine, vol. 57, no. 1, pp. 9–16, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Ricote and C. K. Glass, “PPARs and molecular mechanisms of transrepression,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1771, no. 8, pp. 926–935, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. D. S. Straus and C. K. Glass, “Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms,” Trends in Immunology, vol. 28, no. 12, pp. 551–558, 2007. View at Publisher · View at Google Scholar · View at Scopus
  117. A. M. Sharma and B. Staels, “Review: peroxisome proliferator-activated receptor γ and adipose tissue—understanding obesity-related changes in regulation of lipid and glucose metabolism,” The Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 2, pp. 386–395, 2007. View at Publisher · View at Google Scholar · View at Scopus
  118. F. M. Ivey, A. S. Ryan, C. E. Hafer-Macko et al., “High prevalence of abnormal glucose metabolism and poor sensitivity of fasting plasma glucose in the chronic phase of stroke,” Cerebrovascular Diseases, vol. 22, no. 5-6, pp. 368–371, 2006. View at Publisher · View at Google Scholar · View at Scopus
  119. B. H. Goodpaster, F. L. Thaete, J.-A. Simoneau, and D. E. Kelley, “Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat,” Diabetes, vol. 46, no. 10, pp. 1579–1585, 1997. View at Publisher · View at Google Scholar · View at Scopus
  120. J. V. Francica, A. Bigongiari, L. Mochizuki, M. L. J. Miranda, and B. Rodrigues, “Aerobic program in persons with stroke: a systematic review,” Acta Medica Portuguesa, vol. 27, no. 1, pp. 108–115, 2014. View at Publisher · View at Google Scholar · View at Scopus
  121. F. M. Ivey, C. E. Hafer-Macko, A. S. Ryan, and R. F. MacKo, “Impaired leg vasodilatory function after stroke: adaptations with treadmill exercise training,” Stroke, vol. 41, no. 12, pp. 2913–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  122. F. M. Ivey, A. S. Ryan, C. E. Hafer-Macko, A. P. Goldberg, and R. F. Macko, “Treadmill aerobic training improves glucose tolerance and indices of insulin sensitivity in disabled stroke survivors: A Preliminary Report,” Stroke, vol. 38, no. 10, pp. 2752–2758, 2007. View at Publisher · View at Google Scholar · View at Scopus
  123. B. M. Quaney, L. A. Boyd, J. M. McDowd et al., “Aerobic exercise improves cognition and motor function poststroke,” Neurorehabilitation and Neural Repair, vol. 23, no. 9, pp. 879–885, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. T. B. Cumming, K. Tyedin, L. Churilov, M. E. Morris, and J. Bernhardt, “The effect of physical activity on cognitive function after stroke: a systematic review,” International Psychogeriatrics, vol. 24, no. 4, pp. 557–567, 2012. View at Publisher · View at Google Scholar · View at Scopus
  125. E. Tiozzo, M. Youbi, K. Dave et al., “Aerobic, resistance, and cognitive exercise training poststroke,” Stroke, vol. 46, no. 7, pp. 2012–2016, 2015. View at Publisher · View at Google Scholar · View at Scopus
  126. U.-B. Flansbjer, M. Miller, D. Downham, and J. Lexell, “Progressive resistance training after stroke: effects on muscle strength, muscle tone, gait performance and perceived participation,” Journal of Rehabilitation Medicine, vol. 40, no. 1, pp. 42–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. M. M. Ouellette, N. K. LeBrasseur, J. F. Bean et al., “High-intensity resistance training improves muscle strength, self-reported function, and disability in long-term stroke survivors,” Stroke, vol. 35, no. 6, pp. 1404–1409, 2004. View at Publisher · View at Google Scholar · View at Scopus
  128. H. J. Coelho Júnior, S. D. S. Aguiar, I. D. O. Gonçalves et al., “Sarcopenia is associated with high pulse pressure in older women,” Journal of Aging Research, vol. 2015, Article ID 109824, 6 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  129. R. A. C. Sampaio, P. Y. Sewo Sampaio, M. Yamada et al., “Arterial stiffness is associated with low skeletal muscle mass in Japanese community-dwelling older adults,” Geriatrics & Gerontology International, vol. 14, supplement 1, pp. 109–114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  130. K. Han, Y.-M. Park, H.-S. Kwon et al., “Sarcopenia as a determinant of blood pressure in older Koreans: findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008–2010,” PLoS ONE, vol. 9, no. 1, Article ID e86902, 2014. View at Publisher · View at Google Scholar · View at Scopus
  131. K.-S. Kim, K.-S. Park, M.-J. Kim, S.-K. Kim, Y.-W. Cho, and S. W. Park, “Type 2 diabetes is associated with low muscle mass in older adults,” Geriatrics and Gerontology International, vol. 14, supplement 1, pp. 115–121, 2014. View at Publisher · View at Google Scholar · View at Scopus
  132. F. Lauretani, C. R. Russo, S. Bandinelli et al., “Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia,” Journal of Applied Physiology, vol. 95, no. 5, pp. 1851–1860, 2003. View at Publisher · View at Google Scholar · View at Scopus
  133. A. J. Cruz-Jentoft, J. P. Baeyens, J. M. Bauer et al., “Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People,” Age and Ageing, vol. 39, no. 4, pp. 412–423, 2010. View at Publisher · View at Google Scholar
  134. V. I. Kalapotharakos, M. Michalopoulos, S. P. Tokmakidis, G. Godolias, and V. Gourgoulis, “Effects of a heavy and a moderate resistance training on functional performance in older adults,” Journal of Strength & Conditioning Research, vol. 19, no. 3, pp. 652–657, 2005. View at Publisher · View at Google Scholar · View at Scopus
  135. V. I. Kalapotharakos, M. Michalopoulou, G. Godolias, S. P. Tokmakidis, P. V. Malliou, and V. Gourgoulis, “The effects of high- and moderate-resistance training on muscle function in the elderly,” Journal of Aging and Physical Activity, vol. 12, no. 2, pp. 131–143, 2004. View at Google Scholar · View at Scopus
  136. M. G. Villanueva, J. He, and E. T. Schroeder, “Periodized resistance training with and without supplementation improve body composition and performance in older men,” European Journal of Applied Physiology, vol. 114, no. 5, pp. 891–905, 2014. View at Publisher · View at Google Scholar · View at Scopus
  137. B. K. Pedersen, T. C. A. Åkerström, A. R. Nielsen, and C. P. Fischer, “Role of myokines in exercise and metabolism,” Journal of Applied Physiology, vol. 103, no. 3, pp. 1093–1098, 2007. View at Publisher · View at Google Scholar · View at Scopus
  138. B. Rodrigues, A. A. Santana, A. B. Santamarina et al., “Role of training and detraining on inflammatory and metabolic profile in infarcted rats: influences of cardiovascular autonomic nervous system,” Mediators of Inflammation, vol. 2014, Article ID 207131, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  139. F. S. Lira, A. S. Yamashita, J. C. Rosa et al., “Hypothalamic inflammation is reversed by endurance training in anorectic-cachectic rats,” Nutrition & Metabolism, vol. 8, article 60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  140. F. S. Lira, C. H. Koyama, A. S. Yamashita et al., “Chronic exercise decreases cytokine production in healthy rat skeletal muscle,” Cell Biochemistry and Function, vol. 27, no. 7, pp. 458–461, 2009. View at Publisher · View at Google Scholar · View at Scopus
  141. S. G. da Silva, P. S. Simões, R. A. Mortara et al., “Exercise-induced hippocampal anti-inflammatory response in aged rats,” Journal of Neuroinflammation, vol. 10, article 61, 2013. View at Publisher · View at Google Scholar
  142. S. Adamopoulos, J. Parissis, C. Kroupis et al., “Physical training reduces peripheral markers of inflammation in patients with chronic heart failure,” European Heart Journal, vol. 22, no. 9, pp. 791–797, 2001. View at Publisher · View at Google Scholar · View at Scopus
  143. W. A. Lopes, N. Leite, L. R. da Silva et al., “Effects of 12 weeks of combined training without caloric restriction on inflammatory markers in overweight girls,” Journal of Sports Sciences, vol. 34, no. 20, pp. 1902–1912, 2016. View at Publisher · View at Google Scholar · View at Scopus
  144. O. S. Gondim, V. T. N. De Camargo, F. A. Gutierrez et al., “Benefits of regular exercise on inflammatory and cardiovascular risk markers in normal weight, overweight and obese adults,” PLoS ONE, vol. 10, no. 10, Article ID e0140596, 2015. View at Publisher · View at Google Scholar · View at Scopus
  145. Y. Hayashino, J. L. Jackson, T. Hirata et al., “Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: a meta-analysis of randomized controlled trials,” Metabolism: Clinical and Experimental, vol. 63, no. 3, pp. 431–440, 2014. View at Publisher · View at Google Scholar · View at Scopus
  146. M. M. Shamsi, M. Mahdavi, L. S. Quinn, R. Gharakhanlou, and A. Isanegad, “Effect of resistance exercise training on expression of Hsp70 and inflammatory cytokines in skeletal muscle and adipose tissue of STZ-induced diabetic rats,” Cell Stress and Chaperones, 2016. View at Publisher · View at Google Scholar
  147. M. M. Shamsi, Z. H. Hassan, R. Gharakhanlou et al., “Expression of interleukin-15 and inflammatory cytokines in skeletal muscles of STZ-induced diabetic rats: effect of resistance exercise training,” Endocrine, vol. 46, no. 1, pp. 60–69, 2014. View at Publisher · View at Google Scholar · View at Scopus
  148. L. A. Perandini, A. L. de Sá-Pinto, H. Roschel et al., “Exercise as a therapeutic tool to counteract inflammation and clinical symptoms in autoimmune rheumatic diseases,” Autoimmunity Reviews, vol. 12, no. 2, pp. 218–224, 2012. View at Publisher · View at Google Scholar · View at Scopus
  149. C. R. Neefkes-Zonneveld, A. J. Bakkum, N. C. Bishop, M. W. Van Tulder, and T. W. Janssen, “Effect of long-term physical activity and acute exercise on markers of systemic inflammation in persons with chronic spinal cord injury: a systematic review,” Archives of Physical Medicine and Rehabilitation, vol. 96, no. 1, pp. 30–42, 2015. View at Publisher · View at Google Scholar · View at Scopus
  150. C. P. Lambert, N. R. Wright, B. N. Finck, and D. T. Villareal, “Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons,” Journal of Applied Physiology, vol. 105, no. 2, pp. 473–478, 2008. View at Publisher · View at Google Scholar · View at Scopus
  151. L. A. Perandini, D. Sales-De-Oliveira, S. B. V. Mello et al., “Exercise training can attenuate the inflammatory milieu in women with systemic lupus erythematosus,” Journal of Applied Physiology, vol. 117, no. 6, pp. 639–647, 2014. View at Publisher · View at Google Scholar · View at Scopus
  152. R. V. T. Santos, V. A. R. Viana, R. A. Boscolo et al., “Moderate exercise training modulates cytokine profile and sleep in elderly people,” Cytokine, vol. 60, no. 3, pp. 731–735, 2012. View at Publisher · View at Google Scholar · View at Scopus
  153. A. S. Yamashita, F. S. Lira, J. C. Rosa et al., “Depot-specific modulation of adipokine levels in rat adipose tissue by diet-induced obesity: the effect of aerobic training and energy restriction,” Cytokine, vol. 52, no. 3, pp. 168–174, 2010. View at Publisher · View at Google Scholar · View at Scopus
  154. B. Rodrigues, F. S. Lira, F. M. Consolim-Colombo et al., “Role of exercise training on autonomic changes and inflammatory profile induced by myocardial infarction,” Mediators of Inflammation, vol. 2014, Article ID 702473, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  155. A. K. Boehme, L. A. McClure, Y. Zhang et al., “Inflammatory markers and outcomes after lacunar stroke levels of inflammatory markers in treatment of stroke study,” Stroke, vol. 47, no. 3, pp. 659–667, 2016. View at Google Scholar
  156. N. Mathur and B. K. Pedersen, “Exercise as a mean to control low-grade systemic inflammation,” Mediators of Inflammation, vol. 2008, Article ID 109502, 6 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  157. Z. Xing, J. Gauldie, G. Cox et al., “IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses,” Journal of Clinical Investigation, vol. 101, no. 2, pp. 311–320, 1998. View at Publisher · View at Google Scholar · View at Scopus
  158. K. Ostrowski, T. Rohde, S. Asp, P. Schjerling, and B. K. Pedersen, “Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans,” The Journal of Physiology, vol. 515, no. 1, pp. 287–291, 1999. View at Publisher · View at Google Scholar · View at Scopus
  159. A. Steensberg, C. P. Fischer, C. Keller, K. Møller, and B. K. Pedersen, “IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans,” American Journal of Physiology—Endocrinology and Metabolism, vol. 285, no. 2, pp. E433–E437, 2003. View at Publisher · View at Google Scholar · View at Scopus
  160. A. Steensberg, M. A. Febbraio, T. Osada et al., “Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content,” The Journal of Physiology, vol. 537, no. 2, pp. 633–639, 2001. View at Publisher · View at Google Scholar · View at Scopus
  161. B. K. Pedersen and C. P. Fischer, “Physiological roles of muscle-derived interleukin-6 in response to exercise,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 10, no. 3, pp. 265–271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  162. K. Ostrowski, P. Schjerling, and B. K. Pedersen, “Physical activity and plasma interleukin-6 in humans—effect of intensity of exercise,” European Journal of Applied Physiology, vol. 83, no. 6, pp. 512–515, 2000. View at Publisher · View at Google Scholar · View at Scopus
  163. R. Starkie, S. R. Ostrowski, S. Jauffred, M. Febbraio, and B. K. Pedersen, “Exercise and IL-6 infusion inhibit endotoxin-induced TNF-α production in humans,” The FASEB Journal, vol. 17, no. 8, pp. 884–886, 2003. View at Google Scholar · View at Scopus
  164. T. R. Bernik, S. G. Friedman, M. Ochani et al., “Pharmacological stimulation of the cholinergic antiinflammatory pathway,” The Journal of Experimental Medicine, vol. 195, no. 6, pp. 781–788, 2002. View at Publisher · View at Google Scholar · View at Scopus
  165. V. A. Pavlov and K. J. Tracey, “The cholinergic anti-inflammatory pathway,” Brain, Behavior, and Immunity, vol. 19, no. 6, pp. 493–499, 2005. View at Publisher · View at Google Scholar · View at Scopus
  166. K. J. Tracey, “The inflammatory reflex,” Nature, vol. 420, no. 6917, pp. 853–859, 2002. View at Publisher · View at Google Scholar · View at Scopus
  167. J. F. Machi, D. da Silva Dias, S. Freitas et al., “Impact of aging on cardiac function in a female rat model of menopause: role of autonomic control, inflammation, and oxidative stress,” Clinical Interventions in Aging, vol. 2016, no. 11, pp. 341–350, 2016. View at Publisher · View at Google Scholar
  168. J. A. Rocha, S. P. Ribeiro, C. M. França et al., “Increase in cholinergic modulation with pyridostigmine induces anti-inflammatory cell recruitment soon after acute myocardial infarction in rats,” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 310, no. 8, pp. R697–R706, 2016. View at Publisher · View at Google Scholar
  169. K. J. Tracey, “Reflex control of immunity,” Nature Reviews Immunology, vol. 9, no. 6, pp. 418–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  170. V. A. Pavlov, M. Ochani, M. Gallowitsch-Puerta et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 13, pp. 5219–5223, 2006. View at Publisher · View at Google Scholar · View at Scopus
  171. V. A. Pavlov and K. J. Tracey, “The vagus nerve and the inflammatory reflex—linking immunity and metabolism,” Nature Reviews Endocrinology, vol. 8, no. 12, pp. 743–754, 2012. View at Publisher · View at Google Scholar · View at Scopus
  172. V. A. Pavlov, H. Wang, C. J. Czura, S. G. Friedman, and K. J. Tracey, “The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation,” Molecular Medicine, vol. 9, no. 5–8, pp. 125–134, 2003. View at Google Scholar · View at Scopus
  173. M. Rosas-Ballina and K. J. Tracey, “Cholinergic control of inflammation,” Journal of Internal Medicine, vol. 265, no. 6, pp. 663–679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  174. A. R. Crossman and D. Neary, Neuroanatomia Ilustrada, Elsevier, Sao Paulo, Brazil, 2011.
  175. L. V. Borovikova, S. Ivanova, D. Nardi et al., “Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation,” Autonomic Neuroscience: Basic & Clinical, vol. 85, no. 1-3, pp. 141–147, 2000. View at Publisher · View at Google Scholar · View at Scopus
  176. L. V. Borovikova, S. Ivanova, M. Zhang et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, no. 6785, pp. 458–462, 2000. View at Publisher · View at Google Scholar · View at Scopus
  177. S. Guarini, D. Altavilla, M.-M. Cainazzo et al., “Efferent vagal fibre stimulation blunts nuclear factor-κB activation and protects against hypovolemic hemorrhagic shock,” Circulation, vol. 107, no. 8, pp. 1189–1194, 2003. View at Publisher · View at Google Scholar · View at Scopus
  178. V. A. Pavlov and K. J. Tracey, “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, no. 6, pp. 1037–1040, 2006. View at Publisher · View at Google Scholar · View at Scopus
  179. H. Wang, M. Yu, M. Ochani et al., “Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation,” Nature, vol. 421, no. 6921, pp. 384–388, 2003. View at Publisher · View at Google Scholar · View at Scopus
  180. F. Colivicchi, A. Bassi, M. Santini, and C. Caltagirone, “Cardiac autonomic derangement and arrhythmias in right-sided stroke with insular involvement,” Stroke, vol. 35, no. 9, pp. 2094–2098, 2004. View at Publisher · View at Google Scholar · View at Scopus
  181. A. McLaren, S. Kerr, L. Allan et al., “Autonomic function is impaired in elderly stroke survivors,” Stroke, vol. 36, no. 5, pp. 1026–1030, 2005. View at Publisher · View at Google Scholar · View at Scopus
  182. K. J. Tracey, “Physiology and immunology of the cholinergic antiinflammatory pathway,” The Journal of Clinical Investigation, vol. 117, no. 2, pp. 289–296, 2007. View at Publisher · View at Google Scholar · View at Scopus
  183. F. F. Conti, J. D. O. Brito, N. Bernardes et al., “Positive effect of combined exercise training in a model of metabolic syndrome and menopause: autonomic, inflammatory, and oxidative stress evaluations,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 309, no. 12, pp. R1532–R1539, 2016. View at Publisher · View at Google Scholar · View at Scopus
  184. I. Ay, R. Nasser, B. Simon, and H. Ay, “Transcutaneous cervical vagus nerve stimulation ameliorates acute ischemic injury in rats,” Brain Stimulation, vol. 9, no. 2, pp. 166–173, 2016. View at Publisher · View at Google Scholar
  185. Y. Jiang, L. Li, B. Liu, Y. Zhang, Q. Chen, and C. Li, “Vagus nerve stimulation attenuates cerebral ischemia and reperfusion injury via endogenous cholinergic pathway in rat,” PLoS ONE, vol. 9, no. 7, article e102342, 2014. View at Publisher · View at Google Scholar · View at Scopus